2America Diabetes Association. Peripheral Arterial Disease in People With Diabetes[J], Diabetes Care, 2003,26 (12) : 3333- 3341.
3McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment[J]. JAMA, 2001,286 ( 13 ) : 1599- 1606.
4Koivunen K,Lukkarinen H. Lower limb atherosclerotic disease causes various deteriorations of patients' health-related quality of life[J]. J Vasc Nurs,2006,24(4) :102-115.
5Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease[J]. J Am Coil Cardiol, 47(6): 1239-1312.
6Verspaget M, Nicolas SP, Kruidenier LM,et al. Vadiation of the Dutch version of the walking impairment questionnaire[J]. Eur J Endovasc surg,2009,37(1):51-56.
7Imfeld S, Singer L,Degischer S, et al. Quality of life improvement after hospital-based rehabilitation or home-based physical training in intermittent claudieation[J ]. VASA, 2006,35 (3) : 178-184.
8Regensteiner JG, Steiner JF, Panzer RJ, et al. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease[J]. Vasc Med Biol, 1990,2: 142-152.
9McDermott MM, Liu K,Guralnik JM, et al. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease[J]. J Vase Surg, 1998, 28(6) :1072-1081.
10Myers SA, Johanning J M, Stergiou N, et al. Claudication distances and the walking impairment questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease[J]. J Vase Surg, 2008, 47 ( 3 ) : 550- 555.
4Matsuo H,Shigematsu H.Patient-based outcomes using the Walking Impairment Questionnaire for patients with peripheral arterial occlusive disease treated with Lipo--PGE 1 [J ].Cire J,2010,74 (2) : 365-370.
5Ahn JI-I,Kim TY,Kim YJ,et al.Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes [J ] .Diabet Med, 2006, 23(12):1 339-1 343.
6Regensteiner JG, Ware JE, McCarthy WJ, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health- re- lated quality of life in patients with in termittent claudication due to peripheral arterial disease:meta-analysis of six randomized controlled trials[J]. J Am Geriatr Soc, 2002, 50(12) : 1 939-1 946.
7McDermott MM, Ferrueci L, Guralnik JM, et al. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease [J ]. Vasc Med, 2010 , 15(4) :251-257.
